Answers are grounded in this paper and cite their sources.
Our aim was to evaluate the agreement between Xpert MTB/Rif or Ultra, Xpert MTB/XDR, line probe assays (LPAs), and moxifloxacin pDST for detecting antitubercular drug resistance in children. We found Xpert MTB/XDR showed good concordance with LPAs. It may be considered as a stand-alone test to determine the type of DR-TB and devise a second-line regime upfront.
No takes yet. Share an insight, caveat, or question.
Gandhi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: